Kalaris Therapeutics names CFO
Kalaris Therapeutics named Liisa Bayko Chief Financial Officer effective July 20, 2026. She will serve as CFO until the term ends, though the document displays a dated Future Date.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day